SAN DIEGO, CALIFORNIA / ACCESS Newswire / September 29, 2025 / Faro, the pioneer in AI-powered clinical protocol design, has ...

In the past few years, the healthcare world has faced some of its toughest challenges the COVID-19 pandemic was a wake up call for everyone especially for those involved in clinical trials many trials ...

The COVID-19 pandemic is halting and slowing down clinical trials, and the Food and Drug Administration is offering guidelines to adjust to these new challenges. Clinical trials may slow, stop or ...

Over the past several years, the number of deviations and substantial amendments made to clinical trial protocols has increased notably, contributing to delays in drug development and rising costs for ...

The Subject Expert Committee (SEC), functioning under the Central Drugs Standard Control Organisation (CDSCO), has asked ...

The evolution of clinical trials shows that although much has changed, several things remain the same. When a patient expresses interest in a trial, they complete an informed consent process, and ...

The various roles for oncology nurses in the conduct of clinical trials were described in a presentation at the 2025 ONS Bridge virtual meeting.

Napo Obtains IRB Approval For Phase 3 Clinical Trial Protocol For Crofelemer In HIV/AIDS Diarrhea Assessment Napo Pharmaceuticals, Inc. announces today that it has received approval from the principal ...

Better, faster, cheaper is the aspiration for many innovations including those affecting pharmaceutical trials. A recent study from the respected Tufts Center for the Study of Drug Development (CSDD) ...